Results 291 to 300 of about 141,437 (356)

Diosgenin in polyendocrine metabolic ovarian syndrome: modulation of insulin resistance, inflammation, steroidogenesis, and metabolic dysfunction. [PDF]

Front Endocrinol (Lausanne)
Pugalendhi MA, Sankarganesh D.
europepmc   +1 more source

Androgen insensitivity syndrome. Case report

Valentina V. Kopeikina, О.В. Бородина, Vera V. Marchenko   +2 more
openalex   +1 more source

Glucocorticoid reduction after starting crinecerfont in adult patients with classic CAH: practical perspectives.

J Clin Endocrinol Metab
Hamidi O, Auchus RJ, Correa R, Levine AC, Wierman ME, Hartzell AL, Lin VH, Bancos I.   +7 more
europepmc   +1 more source

Androgen metabolism in prostate cancer: recent advances.

Endocrinology
Sharifi N.
europepmc   +1 more source

Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women

Schiffer L, Anthony AV, Wittemans LBL, Taylor AE, Oestlund I, Miranda AM, Melson E, McDonnell T, Kempegowda P, Smith P, Clark TJ, Wabitsch M, O’Reilly MW, Peters M, Wagenfeld A, Ingwersen J, Snoep JL, Scott WR, Hilpert J, Storbeck K, Arlt W.   +20 more
europepmc   +1 more source

Androgens and Bone [PDF]

Endocrine Reviews, 2004
Loss of estrogens or androgens increases the rate of bone remodeling by removing restraining effects on osteoblastogenesis and osteoclastogenesis, and also causes a focal imbalance between resorption and formation by prolonging the lifespan of ...
Liesbeth Vandenput, Roger Bouillon, Claes Ohlsson   +2 more
exaly   +4 more sources